CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.
Jin AL, Zhang CY, Zheng WJ, Xian JR, Yang WJ, Liu T, Chen W, Li T, Wang BL, Pan BS, Li Q, Cheng JW, Wang PX, Hu B, Zhou J, Fan J, Yang XR, Guo W.
Jin AL, et al. Among authors: liu t.
Clin Transl Med. 2022 Apr;12(4):e794. doi: 10.1002/ctm2.794.
Clin Transl Med. 2022.
PMID: 35384345
Free PMC article.